Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06547281
What this trial is testing

Machine Learning Prediction of Multiple Infections in Elderly Surgical Patients

Who this might be right for
Postoperative InfectionGeriatricsPrediction
Weidong Mi 42,540
Not applicableStudy completedNCT00692965
What this trial is testing

Sleep Quality and Presence of Sleep Disordered Breathing

Who this might be right for
HIV InfectionsSleep
University of Florida 74
Not applicableStudy completedNCT04992000
What this trial is testing

Self-Care of Hypertension Among Older Adults During COVID-19

Who this might be right for
Hypertension
Near East University, Turkey 120
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)Study completedNCT00711802
What this trial is testing

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 396
Post-approval studies (Phase 4)Study completedNCT01949675
What this trial is testing

Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

Who this might be right for
Cholera
Sanofi Pasteur, a Sanofi Company 336
Large-scale testing (Phase 3)Active Not RecruitingNCT06632912
What this trial is testing

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Who this might be right for
Human Papillomavirus (HPV) InfectionHPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China 1,800
Not applicableEnded earlyNCT04414319
What this trial is testing

Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly

Who this might be right for
SARS-CoV 2
University Hospital Center of Martinique 170
Not applicableStudy completedNCT01873365
What this trial is testing

Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above

Who this might be right for
Herpes Zoster
GlaxoSmithKline 448
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Testing effectiveness (Phase 2)Study completedNCT00952419
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 474
Large-scale testing (Phase 3)Study completedNCT01082367
What this trial is testing

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Who this might be right for
Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00434577
What this trial is testing

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Who this might be right for
Herpes Zoster
GlaxoSmithKline 715
Post-approval studies (Phase 4)Study completedNCT01752881
What this trial is testing

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Adimmune Corporation 130
Not applicableStudy completedNCT06387511
What this trial is testing

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

Who this might be right for
Immunization CoverageVaccinationNutrition
Alliance for International Medical Action 3,814
Not applicableUnknownNCT04131465
What this trial is testing

Home HIV Testing for Older Adults in South Africa

Who this might be right for
HIV InfectionsKnowledge, Attitudes, Practice
Harvard School of Public Health (HSPH) 3,578
Large-scale testing (Phase 3)Study completedNCT05398848
What this trial is testing

Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 7,623
Next Page